Phio Pharmaceuticals

Coming – May 19

Innovations In Skin Cancer Treatment and Prevention

Date and Time

May 19

–

4:00 PM ET / 1:00 PM Pt

Details will be provided upon RSVP approval

About this Event

Summer time is prime time for spending time outdoors; at the beach, on the golf course, at a ballgame, and even just the patio, which also makes it prime time for skin cancer.

This fireside chat brings together leaders at the forefront of innovation in skin cancer care to explore both prevention and next-generation treatment strategies. Our featured speakers are:
  • Mary Spellman, M.D.: Board-certified, licensed dermatologist, She held senior positions in medical research and development Biogen, Novartis, and other leading biotech companies.
  • Robert Bitterman: President and CEO of Phio Pharmaceutical, a biotech innovator that is advancing new pathways toward a cancer free future.

The conversation will highlight how novel approaches are designed to enhance the immune system’s ability to target and eliminate cancer cells, including difficult-to-treat skin cancers like cutaneous squamous cell carcinoma and melanoma. Speakers will also address evolving standards in prevention, early detection, and patient management, offering insights into how emerging therapies may complement or even replace traditional surgical interventions.

Register today to join this fireside chat for a clear view of where dermatologic oncology is headed, combining scientific innovation, clinical expertise, and practical perspectives on improving patient outcomes.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.